NYSE:AXSAxis Capital Stock Price, Forecast & News

Axis Capital's stock was trading at $48.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXS stock has decreased by 19.2% and is now trading at $38.87. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axis Capital in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Axis Capital.

Axis Capital is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Axis Capital.

Axis Capital will be holding an earnings conference call on Tuesday, July 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Axis Capital Holdings Limited (NYSE:AXS) released its earnings results on Monday, May, 4th. The insurance provider reported ($1.94) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.92) by $0.02. The insurance provider earned $1.68 billion during the quarter, compared to the consensus estimate of $1.94 billion. Axis Capital had a net margin of 0.73% and a negative return on equity of 0.38%. The firm's revenue was down 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.24 earnings per share. View Axis Capital's earnings history.

Axis Capital declared a quarterly dividend on Thursday, May 7th. Investors of record on Monday, June 29th will be paid a dividend of $0.41 per share on Wednesday, July 15th. This represents a $1.64 annualized dividend and a yield of 4.22%. The ex-dividend date of this dividend is Friday, June 26th. View Axis Capital's dividend history.

6 equities research analysts have issued 12-month price objectives for Axis Capital's stock. Their forecasts range from $40.00 to $75.00. On average, they expect Axis Capital's share price to reach $59.50 in the next year. This suggests a possible upside of 53.1% from the stock's current price. View analysts' price targets for Axis Capital.

News headlines about AXS stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Axis Capital earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned media stories about the insurance provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Axis Capital.

Axis Capital saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 1,290,000 shares, an increase of 15.2% from the June 15th total of 1,120,000 shares. Based on an average daily volume of 953,000 shares, the short-interest ratio is presently 1.4 days. Currently, 1.6% of the shares of the company are sold short. View Axis Capital's Current Options Chain.

Some companies that are related to Axis Capital include Berkshire Hathaway (BRK.B), Progressive (PGR), Travelers Companies (TRV), Allstate (ALL), Markel (MKL), Arch Capital Group (ACGL), Cincinnati Financial (CINF), W. R. Berkley (WRB), Fidelity National Financial (FNF), Erie Indemnity (ERIE), Cna Financial (CNA), First American Financial (FAF), Old Republic International (ORI), Hanover Insurance Group (THG) and RLI (RLI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Axis Capital investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Rogers Communications (RCI), Wheaton Precious Metals (WPM), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX).

Axis Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "AXS."

Axis Capital's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wedge Capital Management L L P NC (1.83%), Envestnet Asset Management Inc. (0.02%), Whittier Trust Co. (0.01%) and CHICAGO TRUST Co NA (0.01%). Company insiders that own Axis Capital stock include Albert Benchimol, Anne Melissa Dowling, Charles A Davis, Henry B Smith, Michael A Butt and Peter Vogt. View institutional ownership trends for Axis Capital.

AXS stock was sold by a variety of institutional investors in the last quarter, including Whittier Trust Co.. View insider buying and selling activity for Axis Capital.

AXS stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, CHICAGO TRUST Co NA, and Envestnet Asset Management Inc.. Company insiders that have bought Axis Capital stock in the last two years include Albert Benchimol, Anne Melissa Dowling, Charles A Davis, Michael A Butt, and Peter Vogt. View insider buying and selling activity for Axis Capital.

Shares of AXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AXS stock can currently be purchased for approximately $38.87.

Axis Capital has a market capitalization of $3.28 billion and generates $5.17 billion in revenue each year. The insurance provider earns $323.47 million in net income (profit) each year or $2.52 on an earnings per share basis. Axis Capital employs 1,667 workers across the globe.

The official website for Axis Capital is www.axiscapital.com.

Axis Capital's mailing address is 92 PITTS BAY ROAD, PEMBROKE D0, HM 08. The insurance provider can be reached via phone at 441-496-2600 or via email at [email protected]